Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study

Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study in Rural Area

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Aims: (1) to Establish the FLS services at the National Taiwan University Hospital Jinshan Branch. (2) To establish a anti-osteoporosis medication management service at Jinshan Branch. Method: From Aug., 2015, a fracture liaison services (FLSs) following the 13 'Capture the Fracture Best Practice Standards' were implemented at the National Taiwan University Hospital Jinshan Branch health care system. The Jinshan Branch program enrolled patient with 1) new hip fracture 2) newly identified vertebral fractures (radiological or clinical) from both inpatients and outpatients. At the same time, a osteoporosis medication management service is also establish as a complement of FLS to enroll patients on antiosteoporosis medications (AOMs) but not necessary with fracture. Participating physicians will select those eligible for services and refer to study coordinators. Study coordinators will conduct baseline assessments on osteoporosis/fracture risks, record medical conditions, AOMs, provide educations on osteoporosis, fracture, sarcopenia, fall, medications, nutrition, and exercise. They also arrange return clinic visit, telephone reminder and follow up for patients, and communicate with providers on regular bases. During the whole study period, the investigators planed to enroll 200 patients (with or without fracture). Each patient would be assessed at baseline, and every 4 months last for two years.

Who May Be Eligible (Plain English)

Who May Qualify: - Age \>=50 and one of the below - New hip fracture in orthopedic ward - Newly identified radiographic vertebral fractures from plan films in geriatric ward or clinical vertebral fractures in outpatient clinics - Newly prescribed with AOMs - Recent change of AOMs - Poor adherence to AOMs - Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements. Who Should NOT Join This Trial: - Life expectancy less than 2 years or can't be assessed for communication problems - Atypical fractures - Patient in other medication clinical trials - Unwilling to accept the assessment and treatment Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age \>=50 and one of the below * New hip fracture in orthopedic ward * Newly identified radiographic vertebral fractures from plan films in geriatric ward or clinical vertebral fractures in outpatient clinics * Newly prescribed with AOMs * Recent change of AOMs * Poor adherence to AOMs * Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements. Exclusion Criteria: * Life expectancy less than 2 years or can't be assessed for communication problems * Atypical fractures * Patient in other medication clinical trials * Unwilling to accept the assessment and treatment

Locations (1)

National Taiwan University Hospital, Chutung branch
Hsinchu, Taiwan